Anixa Biosciences, Inc. (ANIX)
2.75
-0.09
(-3.17%)
USD |
NASDAQ |
Oct 13, 10:40
Anixa Biosciences Net Income (TTM) : -10.47M for July 31, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| July 31, 2026 | -10.47M |
| April 30, 2026 | -10.12M |
| January 31, 2026 | -10.40M |
| October 31, 2025 | -11.03M |
| July 31, 2025 | -11.22M |
| April 30, 2025 | -12.25M |
| January 31, 2025 | -12.62M |
| October 31, 2024 | -12.70M |
| July 31, 2024 | -12.51M |
| April 30, 2024 | -11.74M |
| January 31, 2024 | -10.87M |
| October 31, 2023 | -9.93M |
| July 31, 2023 | -10.74M |
| April 30, 2023 | -10.96M |
| January 31, 2023 | -12.25M |
| October 31, 2022 | -13.77M |
| July 31, 2022 | -14.31M |
| April 30, 2022 | -15.93M |
| January 31, 2022 | -14.77M |
| October 31, 2021 | -13.13M |
| July 31, 2021 | -11.30M |
| April 30, 2021 | -9.487M |
| January 31, 2021 | -9.708M |
| October 31, 2020 | -10.09M |
| July 31, 2020 | -9.962M |
| Date | Value |
|---|---|
| April 30, 2020 | -9.552M |
| January 31, 2020 | -9.469M |
| October 31, 2019 | -11.82M |
| July 31, 2019 | -15.10M |
| April 30, 2019 | -18.53M |
| January 31, 2019 | -17.34M |
| October 31, 2018 | -14.24M |
| July 31, 2018 | -10.64M |
| April 30, 2018 | -6.838M |
| January 31, 2018 | -5.285M |
| October 31, 2017 | -5.009M |
| July 31, 2017 | -4.271M |
| April 30, 2017 | -3.580M |
| January 31, 2017 | -5.013M |
| October 31, 2016 | -5.016M |
| July 31, 2016 | -5.261M |
| April 30, 2016 | -5.760M |
| January 31, 2016 | -6.724M |
| October 31, 2015 | -1.379M |
| July 31, 2015 | -3.240M |
| April 30, 2015 | -1.227M |
| January 31, 2015 | -2.240M |
| October 31, 2014 | -9.606M |
| July 31, 2014 | -9.380M |
| April 30, 2014 | -12.37M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Mera Pharmaceuticals, Inc. | -- |